Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB L-0501 (Bendamustine) in Untreated Multiple Myeloma
NCT01179490Phase 2Terminated
- Sponsor
- SymBio Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by SymBio Pharmaceuticals. Started Sep 2010; status: terminated.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01179490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179490.